D. Barone

460 total citations
12 papers, 312 citations indexed

About

D. Barone is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, D. Barone has authored 12 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in D. Barone's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). D. Barone is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). D. Barone collaborates with scholars based in United States and Canada. D. Barone's co-authors include Jeremy I. Levin, J.S. Skotnicki, K M Mohler, Jun Xu, Terri Cummons, Roy A. Black, Guofeng Jin, Stacey Skala, Anita Sung and Frances C. Nelson and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

D. Barone

12 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Barone United States 8 144 125 74 67 51 12 312
J.S. Skotnicki United States 6 137 1.0× 148 1.2× 102 1.4× 56 0.8× 25 0.5× 8 311
Stacey Skala United States 8 104 0.7× 70 0.6× 62 0.8× 48 0.7× 21 0.4× 8 228
Jonathan Tart United Kingdom 8 283 2.0× 83 0.7× 115 1.6× 43 0.6× 29 0.6× 9 396
Craig Swearingen United States 15 182 1.3× 97 0.8× 107 1.4× 82 1.2× 50 1.0× 21 423
Aaron Maurais United States 7 204 1.4× 71 0.6× 56 0.8× 80 1.2× 34 0.7× 8 364
Daniel Kukral United States 8 105 0.7× 68 0.5× 28 0.4× 61 0.9× 28 0.5× 9 265
Bertrand Heckmann Belgium 11 250 1.7× 103 0.8× 45 0.6× 87 1.3× 16 0.3× 19 425
Minhao Huang China 10 197 1.4× 82 0.7× 22 0.3× 121 1.8× 34 0.7× 19 337
Andrei Y. Volgin United States 5 166 1.2× 123 1.0× 59 0.8× 20 0.3× 84 1.6× 7 357
Mary E. Irwin United States 9 287 2.0× 115 0.9× 88 1.2× 22 0.3× 29 0.6× 11 457

Countries citing papers authored by D. Barone

Since Specialization
Citations

This map shows the geographic impact of D. Barone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Barone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Barone more than expected).

Fields of papers citing papers by D. Barone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Barone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Barone. The network helps show where D. Barone may publish in the future.

Co-authorship network of co-authors of D. Barone

This figure shows the co-authorship network connecting the top 25 collaborators of D. Barone. A scholar is included among the top collaborators of D. Barone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Barone. D. Barone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hayden-Ledbetter, Martha, Erik Espling, William Brady, et al.. (2009). CD20-Directed Small Modular Immunopharmaceutical, TRU-015, Depletes Normal and Malignant B Cells. Clinical Cancer Research. 15(8). 2739–2746. 27 indexed citations
2.
Kivitz, A., et al.. (2007). Phase 1 study of TRU-015, a CD20-directed small modular immunopharmaceutical (SMIP™) protein therapeutic, in subjects with rheumatoid arthritis. Arthritis Research & Therapy. 9(Suppl 3). P31–P31. 3 indexed citations
3.
Barone, D., C. Nilsson, J A Ledbetter, Martha Hayden-Ledbetter, & K M Mohler. (2006). Efficacy of SMIP-016, a novel CD37-directed biologic therapy, in human NHL tumor xenograft models. Journal of Clinical Oncology. 24(18_suppl). 2565–2565. 1 indexed citations
4.
Levin, Jeremy I., Leif M. Laakso, J. Schmid, et al.. (2006). Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates. Bioorganic & Medicinal Chemistry Letters. 16(6). 1605–1609. 37 indexed citations
5.
Zask, Arie, Joshua A. Kaplan, Xuemei Du, et al.. (2005). Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(6). 1641–1645. 23 indexed citations
6.
Barone, D., C. Nilsson, J A Ledbetter, Martha Hayden-Ledbetter, & K M Mohler. (2005). TRU-015, a novel CD20-directed biologic therapy, demonstrates significant anti-tumor activity in human tumor xenograft models. Journal of Clinical Oncology. 23(16_suppl). 2549–2549. 5 indexed citations
7.
Levin, Jeremy I., Frances C. Nelson, Efren Delos Santos, et al.. (2004). Benzodiazepine inhibitors of the MMPs and TACE. Part 2. Bioorganic & Medicinal Chemistry Letters. 14(16). 4147–4151. 17 indexed citations
8.
9.
10.
Zask, Arie, Ying Gu, J. Donald Albright, et al.. (2003). Synthesis and SAR of bicyclic heteroaryl hydroxamic acid MMP and TACE inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(8). 1487–1490. 26 indexed citations
11.
Schuh, JoAnn C. L., et al.. (2002). Periosteal Hyperostosis (Exostosis) in DBA/1 Male Mice. Toxicologic Pathology. 30(3). 390–393. 2 indexed citations
12.
Levin, Jeremy I., Frances C. Nelson, Loran M. Killar, et al.. (2002). Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1′ group. Bioorganic & Medicinal Chemistry Letters. 12(8). 1199–1202. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.S. Skotnicki Breakdown of academic impact, for papers by Stacey Skala Breakdown of academic impact, for papers by Jonathan Tart Breakdown of academic impact, for papers by Craig Swearingen Breakdown of academic impact, for papers by Aaron Maurais Breakdown of academic impact, for papers by Daniel Kukral Breakdown of academic impact, for papers by Bertrand Heckmann Breakdown of academic impact, for papers by Minhao Huang Breakdown of academic impact, for papers by Andrei Y. Volgin Breakdown of academic impact, for papers by Mary E. Irwin
Rankless by CCL
2026